Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
16.6M
-
Shares change
-
+2.29M
-
Total reported value, excl. options
-
$48.7M
-
Value change
-
+$6.78M
-
Put/Call ratio
-
63.87
-
Number of buys
-
53
-
Number of sells
-
-18
-
Price
-
$2.93
Significant Holders of Humacyte, Inc. - COM (HUMA) as of Q3 2023
94 filings reported holding HUMA - Humacyte, Inc. - COM as of Q3 2023.
Humacyte, Inc. - COM (HUMA) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.6M shares
.
Largest 10 shareholders include BlackRock Inc. (4.5M shares), VANGUARD GROUP INC (3.02M shares), GEODE CAPITAL MANAGEMENT, LLC (1.23M shares), MILLENNIUM MANAGEMENT LLC (1.23M shares), STATE STREET CORP (1.13M shares), Prescott General Partners LLC (568K shares), NORTHERN TRUST CORP (519K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (458K shares), GSA CAPITAL PARTNERS LLP (356K shares), and LPL Financial LLC (341K shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.